← Leaderboards
Yan Fang
Ut Southwestern Medical Center
$283,546
Attributed
$283,546
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $106.9K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$283,546 · 2
By mechanism
K00$209,578 · 1
F99$73,968 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Wen Jiang$5,217,879
- Diego H Castrillon$18,503,509
- Chuo Chen$9,073,859
- Nan Yan$13,047,232
- Tao Wang$1,651,809
Others in their field
Other Rising Stars on “Defect”
- Matthew D Galbraith · University Of Colorado Denver$4,352,549
- Ronald Fernando Garcia-Ruiz · Massachusetts Institute Of Technology$4,266,667
- Baodong Sun · Duke University$3,238,660
- David T. Kent · Vanderbilt University Medical Center$3,120,041
- Anca Mirabela Pasca · Stanford University$2,912,854
- Swetha Gowrishankar · University Of Illinois At Chicago$2,883,585
Research focus
DefectAntibodiesAdvanced Malignant NeoplasmAbscopal EffectAntitumor EffectAnti-Tumor Immune ResponseAnti-CancerBackAntigen-Presenting CellsCancer PreventionCancer TherapyCancer Vaccine Related DevelopmentCancer VaccinesCell DeathCell KillingAutophagocytosisCellsCessation Of LifeCancer ImmunotherapyComputational TechniqueCross PresentationCytotoxic T-LymphocytesData AnalysesDesign
Grant awards (4)
Enhancing the antitumor effect of radiation therapy by targeting the cGAS-STING pathway$106,852
K00 · FY2025 · CA · contact PI
Enhancing the antitumor effect of radiation therapy by targeting the cGAS-STING pathway$102,726
K00 · FY2024 · CA · contact PI
Enhancing the antitumor effect of radiation therapy by targeting the cGAS-STING pathway$36,705
F99 · FY2023 · CA · contact PI
Enhancing the antitumor effect of radiation therapy by targeting the cGAS-STING pathway$37,263
F99 · FY2022 · CA · contact PI